Michael Flood

Partner
Norton Rose Fulbright US LLP
michael.flood@nortonrosefulbright.com
Michael
Flood
Michael Flood
St. Louis
Suite 800
8001 Forsyth Blvd
St. Louis
Missouri
63105
United States
+1 314 505 8831

Michael Flood advises healthcare providers, investors and other healthcare industry stakeholders with a practical, business-first approach. He understands the real-world challenges healthcare stakeholders face in the fast-changing regulatory landscape, and provides advice and counsel designed to support compliant and competitive success on transactional and regulatory matters.

Mike helps clients navigate the full lifecycle of healthcare M&A and financing transactions in compliance with state and federal healthcare statutes and regulations with a specific focus on the behavioral health, practice management, pharmacy and durable medical equipment industries.

Additionally, Mike advises on licensure, enrollment and accreditation, compliance with state and federal fraud and abuse laws, including the Anti-Kickback Statute and the Stark Law, the application of corporate practice doctrines and fee-splitting prohibitions on healthcare professionals, state healthcare transaction notification laws and reimbursement requirements of federal healthcare programs and other third-party payors.

Representative experience

  • Advised private equity owned portfolio company on the purchase and integration of several Medicaid Home and Community Based Services waiver funded agencies specializing in providing habilitative services to intellectually and developmentally disabled individuals.
  • Represented sellers on the sale of a multidisciplinary therapy practice (ABA, speech language pathology, physical and occupational therapy) to a private equity fund in a platform acquisition.
  • Regulatory counsel on sale of provider specializing in autism therapy and special educational services to K-12 educational agencies.
  • Provide day-to-day operational counsel to several autism therapy providers, including licensing, reimbursement and corporate practice compliance.
  • Structured and implemented clinical operations in compliance with corporate practice and fee-splitting prohibitions for a de novo multi-site, multi-state eyecare provider.
  • Advised on the acquisition and sale of professional practices in the primary care, women’s health, oncology, autism therapy and dental industries on behalf of private equity backed professional practice management organizations.
  • Advised state university health system in the acquisition of statewide multi-site medical oncology practice, including integration into off-campus hospital outpatient departments.
  • Counseled leading national compounding pharmacy on public policy platform, including strategies relating to section 503A and 503B of the Federal Food, Drug and Cosmetic Act and state regulatory requirements.
  • Seller’s counsel in sale of statewide New York home infusion pharmacy and nursing operations to national private equity backed specialty pharmacy.
  • Led the transfer of over 250 pharmacy licenses, DME permits and Medicare and Medicaid enrollments in the sale of a national specialty pharmacy/DME provider.
  • Regulatory counsel for publicly-traded DME supplier with national operations on several acquisitions.

Awards and recognitions

  • The Best Lawyers in America: Ones to Watch, Healthcare Law, Best Lawyers, 2024-2025

Education

  • JD, Saint Louis University School of Law, 2012
    • Certificate in Health Law
  • BA, Economics, University of Illinois at Urbana-Champaign, 2009

Admissions

  • District of Columbia Bar
  • Illinois State Bar
  • Missouri State Bar

Speaking engagements

  • Panelist, “Which Way Are the Autism Investment Winds Blowing,” Autism Investor Summit, April 7, 2025

Publications

  • Co-author, “A Market in Transition: Autism Therapy Provider M&A,” The National Law Review, March 2024

Membership and activities

  • Gateway Chapter of the National Multiple Sclerosis Society, Board of Trustees
Bio